News
Helsinn Advanced Synthesis, Biasca: Reduces CO2 emissions by 80% and unveils the new anticancer plant
Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai
Farma Industria Ticino in Frankfurt for CPhI Worldwide 2019
Helsinn attends 4th Annual Sino-Swiss Business Awards
La RSI in visita presso alcune aziende industriali del nostro territorio
Helsinn to co-host alongside Recordati Rare Diseases satellite symposium on MF-CTCL diagnosis optimization at European Academy of Dermatology and Venereology Congress 2019
Comunicato stampa “Farma Industria Ticino and Credit Suisse Award for best student”, mercoledì 18 settembre 2019
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma (MF-CTCL) treatment at the 49th European Society for Dermatological Research Annual Meeting 2019
Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology
Progetto Talenti
Cultura e salute
Linkedin